Magnus Medical
PrivateLast Round
Series B
May 9, 2025
Total Funding Raised
$90.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Magnus Medical operates in Healthcare & Life Sciences and is based in Burlingame, California. Its latest recorded funding round was a Series B round in May 2025.
Magnus Medical is a neurotechnology company that develops and commercializes non-invasive, fMRI-guided brain stimulation solutions for treating neurological and psychiatric disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Medical Imaging, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Magnus Medical Comparables
Compare Magnus Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nexstim Oyj | 82% | |
| MagVenture | 79% | |
| Soterix Medical | 78% |
For institutional investors. Book with your work email.
Magnus Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 9, 2025 | ||||
| Series B | May 1, 2025 | ||||
| Series A | Oct 29, 2021 | ||||
| Grant | Sep 15, 2020 |
For institutional investors. Book with your work email.
Magnus Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Mental Health | Grant |
| Dolby Family Ventures | Series B |
| Khosla Ventures | Series B |
| NIH RADx | Grant |
| JAZZ Venture Partners | Series B, Series A |
| Mubadala Investment Company | Series B |
| Red Tree Venture Capital | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 2, 2026
Leveraging Countsy and ZRG Partners for accounting services.
- Oct 1, 2025
SAINT® therapy is now FDA authorized for treatment-resistant depression.
For institutional investors. Book with your work email.
Magnus Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Magnus Medical's valuation, stock price, and market status.
Is Magnus Medical a public or private company?
Magnus Medical is a private company.
What is the current stock price of Magnus Medical?
Magnus Medical is a private company, so its shares have no public market price. Caplight tracks Magnus Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Magnus Medical worth (valuation)?
Valuation information for Magnus Medical is not publicly available.
Can I buy Magnus Medical stock?
Magnus Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Magnus Medical's last funding round?
Magnus Medical's most recent funding round was Series B on May 9, 2025.
Who are the main investors in Magnus Medical?
Key investors in Magnus Medical include JAZZ Venture Partners, Red Tree Venture Capital.
Will Magnus Medical IPO soon?
No public IPO plans have been announced for Magnus Medical.
How can I track Magnus Medical secondary market activity?
Caplight tracks bids, offers, and trades in Magnus Medical's shares on secondary markets.